Carregant...
Baloxavir Marboxil 2% Granules in Japanese Children With Influenza: An Open-label Phase 3 Study
A granule formulation of baloxavir marboxil, a selective inhibitor of influenza cap-dependent endonuclease, was newly developed for children with difficulty swallowing tablets. METHODS: A multicenter open-label study was conducted during the 2017–2018 influenza season to assess the safety, pharmacok...
Guardat en:
| Publicat a: | Pediatr Infect Dis J |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Lippincott Williams & Wilkins
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7360099/ https://ncbi.nlm.nih.gov/pubmed/32433222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0000000000002748 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|